Association of C-reactive protein with the presence and extent of angiographically verified coronary artery disease

Tohoku Journal of Experimental Medicine

Volumn 209, Issue 3, 2006, Pages 197-206

  Memon, Lidija ^a   Spasojević Kalimanovska, Vesna ^b   Bogavac Stanojević, Nataša ^b   Kalimanovska Oštrić, Dimitra ^c   Jelić Ivanović, Zorana ^b   Spasić, Slavica ^b   Topić, Aleksandra ^b  

^a University Clinical Hospital Center Bezanijska Kosa   (Serbia)

^b Faculty of Pharmacy   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Atherosclerosis; Coronary artery disease; Fibrinogen; hsCRP; Inflammation

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FREQUENCY ANALYSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; YUGOSLAVIA;

EID: 33745190255     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.209.197     Document Type: Article

References (29)

1. Albert, M.A., Danielson, E., Rifai, N., Ridker, P.M. & PRICE Investigators PM (2001) Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA, 286, 64-70.
2. Arroyo-Espliguero, R., Avanzas, P., Cosín-Sales, J., Aldama, G., Pizzi, C. & Kaski, J.C. (2004) C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur. Heart J., 25, 401-408.
3. Azar, R.R., Aoun, G., Fram, D.B., Waters, D.D., Wu, A.H.B. & Kiernan, F.J. (2000) Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests. Am. J. Cardiol., 86, 205-207.
4. Danesh, J., Muir, J., Wong, Y.-K., Ward, M., Gallimore, J.R. & Pepys, M.B. (1999) Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur. Heart. J., 20, 954-959.
5. Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G.D.O., Pepys, M.B. & Gudnason, V. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med., 350, 1387-1397.
6. ECAT Angina pectoris Study Group (1993) ECAT angina pectoris study. Baseline associations of haematostatic factors with extent of coronary atherosclerosis and other risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur. Heart J., 14, 8-17.
7. Erren, M., Reinecke, H., Junker, R., Fobker, M., Schulte, H., Schurek, J.O., Kropf, J., Kerber, S., Breithardt, G., Assmann, G. & Cullen, P. (1999) Systematic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler. Thromb. Vasc. Biol., 19, 2355-2363.
8. Hannekens, C.H., Dyken, M.L. & Fuster, V. (1997) Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation, 96, 2751-2753.
9. Haverkate, F., Thompson, S.G., Pyke, S.D.M., Gallimore, J.R. & Pepys, M.B., for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet, 349, 462-466.
10. Hobikoglu, G.F., Norgaz, T., Aksu, H., Ozer, O., Erturk, M., Nurkalem, Z. & Narin, A. (2005) High frequency of aspirin resistance in patients with acute coronary syndrome. Tohoku J. Exp. Med., 207, 59-64.
11. Hoffmeister, A., Rothenbacher, D., Bäzner, U., Frönlich, M., Brenner, H., Hombach, V. & Koenig, W. (2001) Role of novel markers of inflammation in patients with stable coronary heart disease. Am. J. Cardiol., 87, 262-266.
12. Ikonomidis, I., Andreotti, F., Economou, E., Stefanadis, C., Toutouzas, P. & Nihoyannopoulos, P. (1999) Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation, 100, 793-798.
13. Imhof, A., Frönlich, M., Loewel, H., Helbecque, N., Woodward, M., Amouyel, P., Lowe, G.D. & Koenig, W. (2003) Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. Clin. Chem., 49, 669-672.
14. Jousilahti, P., Salomaa, V., Rasi, V., Vahtera, E. & Palosuo, T. (2001) The association of C-reactive protein, serum amyloid A and fibrinogen with prevalent coronary heart disease - baseline findings of the PAIS project. Atherosclerosis, 156, 451-456.
15. Levenson, J., Giral, P., Megnien, J.L., Gariepy, J., Plainfosse, M.C. & Simon, A. (1997) Fibrinogen and its relations to subclinical extracoronary and coronary atherosclerosis in hypercholesterolemic men. Arterio. Thromb. Vasc. Biol., 17, 45-50.
16. Levi, M., van der, P.T. & Buller, H.R. (2004) Bidirectional relation between inflammation and coagulation. Circulation, 109, 2698-2704.
17. Lind, L. (2003) Circulating markers of inflammation and atherosclerosis. Atherosclerosis, 169, 203-214.
18. Lowe, G., Rumley, A., Norrie, J., Ford, I., Shepherd, J., Cobbe, S., Macfarlane, P. & Packard, C., on behalf of the West of Scotland Coronary Prevention Study Group (2000) Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb. Haemost., 84, 553-558.
19. Maresca, G., Di Blasio, A., Marchioli, R. & Di Minno, G. (1999) Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 19, 1368-1377.
20. Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O., Criqui, M., Fadl, Y.Y., Fortmann, S.P., Hong, Y., Myers, G.L., Rifai, N., Smith, S.C., Taubert, J.K., Tracy, R.P. & Vinicor, F. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499-511.
21. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. & Hennekens, C.H. (1997) Inflammation, aspirin, and risk of cardiovascular disease in apparently healthy men. New Engl. J. Med., 336, 973-979.
22. Rifai, N. & Ridker, P.M. (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem., 47, 403-411.
23. Rifai, N. & Ridker, P.M. (2003) Population distributions of C-reactive protein in apparently healthy men and women in the United States: Implication for clinical interpretation. Clin. Chem., 49, 666-669.
24. Ross, R. (1999) Atherosclerosis: an inflammatory disease. N. Eng. J. Med., 340, 115-126.
25. Tamam, Y., Iltumur, K. & Apak, I. (2005) Assessment of acute phase proteins in acute ischemic stroke. Tohoku J. Exp. Med., 206, 91-98.
26. Taniguchi, H., Momiyama, Y., Ohmori, R., Yonemura, A., Yamashita, T., Tamai, S., Nakamura, H. & Ohsuzu, F. (2005) Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atheroscler., 178, 173-177.
27. Tataru, M.C., Heinrich, J., Junker, R., Schulte, H., von Eckardstein, A., Assmann, G. & Koehler, E. (2000) C-Reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur. Heart J., 21, 1000-1008.
28. Yin, W.H., Chen, J.W., Jen, H.L., Chiang, M.C., Huang, W.P., Feng, A.N., Young, M.S. & Lin, S.J. (2004) Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am. Heart J., 147, 931-938.
29. Zebrack, J.S., Muhlestein, J.B., Horne, B.D. & Anderson, J.L. (2002) C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J. Am. Coll. Cardiol., 39, 632-637.